Yong Hwy Kim1, Ji Yeoun Lee1,2,3, Ji Hoon Phi1,2, Kyu-Chang Wang1,2, Seung-Ki Kim4,5. 1. Department of Neurosurgery, Seoul National University Hospital, Seoul, Republic of Korea. 2. Division of Pediatric Neurosurgery, Department of Neurosurgery, Seoul National University Children's Hospital, College of Medicine, Seoul National University, Seoul, Republic of Korea. 3. Department of Anatomy, College of Medicine, Seoul National University, Seoul, Republic of Korea. 4. Department of Neurosurgery, Seoul National University Hospital, Seoul, Republic of Korea. nsthomas@snu.ac.kr. 5. Division of Pediatric Neurosurgery, Department of Neurosurgery, Seoul National University Children's Hospital, College of Medicine, Seoul National University, Seoul, Republic of Korea. nsthomas@snu.ac.kr.
Abstract
PURPOSE: The utility of endoscopic endonasal skull base surgery (EES) in various pathologic entities in adults has been published in the literature. However, the role of EES in children has not been clearly elucidated. We evaluated the feasibility of EES in children with brain tumors. METHODS: We retrospectively reviewed clinical features, surgical outcomes, and complications in children who underwent EES for intracranial and skull base tumors at a single institution from July 2010 to October 2018. RESULTS: A total of 82 patients underwent EESs for 77 intracranial and 5 skull base bony tumors. The mean age at diagnosis was 11.4 years (range 4-18 years), and the mean follow-up period was 46.8 months. The most common tumors were craniopharyngioma in the intracranial tumor and chordoma in the skull base. Gross total resection was the goal of surgery in 55 patients and achieved in 90.9%. The vision was improved in 76.1% of patients with visual impairments. Preoperatively, various endocrinological deficiencies were revealed in 73.7% of 76 patients with hypothalamus-pituitary lesions, and the hyposomatotropism was most common. Endocrinological status was improved only in 10. Aseptic or bacterial meningitis (7.3%) was the most common surgical complication, and the cerebrospinal fluid leakage rate was 2.4%. CONCLUSIONS: EES provides favorable neurological outcomes with acceptable risk for children with brain tumors. The high incidence of endocrinological deficits in cases with hypothalamus-pituitary lesions emphasizes the importance of judicious pre- and postoperative evaluation.
PURPOSE: The utility of endoscopic endonasal skull base surgery (EES) in various pathologic entities in adults has been published in the literature. However, the role of EES in children has not been clearly elucidated. We evaluated the feasibility of EES in children with brain tumors. METHODS: We retrospectively reviewed clinical features, surgical outcomes, and complications in children who underwent EES for intracranial and skull base tumors at a single institution from July 2010 to October 2018. RESULTS: A total of 82 patients underwent EESs for 77 intracranial and 5 skull base bony tumors. The mean age at diagnosis was 11.4 years (range 4-18 years), and the mean follow-up period was 46.8 months. The most common tumors were craniopharyngioma in the intracranial tumor and chordoma in the skull base. Gross total resection was the goal of surgery in 55 patients and achieved in 90.9%. The vision was improved in 76.1% of patients with visual impairments. Preoperatively, various endocrinological deficiencies were revealed in 73.7% of 76 patients with hypothalamus-pituitary lesions, and the hyposomatotropism was most common. Endocrinological status was improved only in 10. Aseptic or bacterial meningitis (7.3%) was the most common surgical complication, and the cerebrospinal fluid leakage rate was 2.4%. CONCLUSIONS: EES provides favorable neurological outcomes with acceptable risk for children with brain tumors. The high incidence of endocrinological deficits in cases with hypothalamus-pituitary lesions emphasizes the importance of judicious pre- and postoperative evaluation.
Authors: Alexander P Kelly; Jeffrey P Greenfield; Georgiana A Dobri; Theodore H Schwartz Journal: Childs Nerv Syst Date: 2022-01-19 Impact factor: 1.475
Authors: Matheus F M Ballestero; Stephanie N F de Souza; Romilto C Pacheco Neto; Guilherme G P Gondim; Elvis T Valera; Maristella B F Dos Reis; Benedicto O Colli; Ricardo S de Oliveira Journal: J Pediatr Neurosci Date: 2021-06-25